Comparison of intrapleural bupivacaine versus bupivacaine plus ketamine on post-thoracoscopy pain control

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201411203915N13

Enrollment

Registered

2014-12-13

Start date

2014-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after surgery. Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Interventions

Intervention 1: patients in group B receive bupivacaine 0.25% infusion 5cc/h after intra- pleural catheter insertion. Intervention 2: patients in group BK receive infusion of bupivacaine 0.25% 5c

Treatment - Drugs

patients in group B receive bupivacaine 0.25% infusion 5cc/h after intra- pleural catheter insertion.

patients in group BK receive infusion of bupivacaine 0.25% 5cc/h and ketamine 5 mg/h after insertion of intra-pleural catheter

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18-60 yr; American Society of Anesthesiologists class 1-2; Exclusion criteria: declined to participate; renal or hepatic failure; systemic hypertension; allergy to bupivacain or opiates; concomitant amiodaron therapy; pregnancy; recent thoracic infection; unable to fill the questionnaire

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain and its severity. Timepoint: Every 6 hour till 24 hour. Method of measurement: Visual analog scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Peirovifar

Tabriz University of Medical Sciences

peirovifara@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026